A Retrospective Cohort Study of Multiple Immune-Related Adverse Events and Clinical Outcomes Among Patients With Cancer Receiving Immune Checkpoint Inhibitors

A Retrospective Cohort Study of Multiple Immune-Related Adverse Events and Clinical Outcomes Among Patients With Cancer Receiving Immune Checkpoint Inhibitors

Background and Objectives Immune checkpoint inhibitors (ICIs) are effective in various types of cancer and cause immune-related adverse events (irAEs). The occurrence of irAEs is associated with improved survival outcome. We investigated the association between the occurrence of irAEs and overall su...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính:	Hiroki Hata MS, Chikako Matsumura PhD, Yugo Chisaki PhD, Kae Nishioka, Misaki Tokuda, Kazuyo Miyagi, Tomoki Suizu MS, Yoshitaka Yano PhD
Định dạng:	Bài viết
Ngôn ngữ:	English
Được phát hành:	SAGE Publishing 2022-09-01
Loạt:	Cancer Control
Truy cập trực tuyến:	https://doi.org/10.1177/10732748221130576

Những quyển sách tương tự

Factors Associated With Efficacy and Nivolumab-Related Interstitial Pneumonia in Non-Small Cell Lung Cancer: A Retrospective Survey
Bằng: Hiroki Hata MS, et al.
Được phát hành: (2020-12-01)

Myocardial Vasculitis Associated With the Immune Checkpoint Inhibitor Pembrolizumab
Bằng: Hideo Oishi, MD, et al.
Được phát hành: (2020-10-01)

Cancer Immune Checkpoint Inhibitor Therapy and the Gut Microbiota
Bằng: Arthur E. Frankel MD, et al.
Được phát hành: (2019-04-01)

Desensitizing Effect of Cancer Cachexia on Immune Checkpoint Inhibitors in Patients With Advanced NSCLC
Bằng: Taichi Miyawaki, MD, et al.
Được phát hành: (2020-06-01)

Inflammatory and immune checkpoint markers are associated with the severity of aortic stenosisCentral MessagePerspective
Bằng: Bilguun Erkhem-Ochir, MD, et al.
Được phát hành: (2021-03-01)

Noninvasive Imaging of Immune Checkpoint Ligand PD-L1 in Tumors and Metastases for Guiding Immunotherapy
Bằng: Samit Chatterjee PhD, et al.
Được phát hành: (2017-07-01)

Overcoming Immunotherapy Resistance With Radiation Therapy and Dual Immune Checkpoint Blockade
Bằng: Tara Davidson, MD, et al.
Được phát hành: (2022-07-01)

Patients With BRAF-Mutant NSCLC May Not Benefit From Immune Checkpoint Inhibitors: A Population-Based Study
Bằng: Chenxing Zhang, PhD, et al.
Được phát hành: (2020-03-01)

Effectiveness and Safety of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in Pulmonary Sarcomatoid Carcinoma
Bằng: Daisuke Hazama, MD, PhD, et al.
Được phát hành: (2024-01-01)

A Case of Lung Cancer with Very-Late-Onset Immune Checkpoint Inhibitor-Related MyocarditisNovel Teaching Points
Bằng: Tatsuya Nishikawa, MD, PhD, et al.
Được phát hành: (2022-07-01)

A Real-World Analysis of Immune Checkpoint Inhibitor-Based Therapy After Osimertinib Treatment in Patients With EGFR-Mutant NSCLC
Bằng: Kenji Morimoto, MD, PhD, et al.
Được phát hành: (2022-09-01)

Late-Onset Giant Cell Myocarditis Due to Enterovirus During Treatment With Immune Checkpoint Inhibitors
Bằng: Mariana Mirabel, MD, PhD, et al.
Được phát hành: (2020-09-01)

A Modified Method for the Quantification of Immune Checkpoint Ligands on Exosomes from Human Serum using Flow Cytometry
Bằng: Alan Guillermo Alejandre Gonzalez PhD, et al.
Được phát hành: (2023-05-01)

A Common Pituitary Autoantibody in Two Patients with Immune Checkpoint Inhibitor-Mediated Hypophysitis: ZCCHC8
Bằng: Amanda Leiter, MD, MSCR, et al.
Được phát hành: (2020-07-01)

Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA Study
Bằng: Yasunori Murata, MD, PhD, et al.
Được phát hành: (2023-12-01)

The Use of Herbal Medicine and Dietary Supplements in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Multicenter Cross-Sectional Study
Bằng: Fatih Kus MD, et al.
Được phát hành: (2024-09-01)

Heterogeneous Outcomes of Immune Checkpoint Inhibitor Rechallenge in Patients With NSCLC: A Systematic Review and Meta-Analysis
Bằng: Shiting Xu, MD, et al.
Được phát hành: (2022-04-01)

Predictive Impact of Diffuse Positivity for TTF-1 Expression in Patients Treated With Platinum-Doublet Chemotherapy Plus Immune Checkpoint Inhibitors for Advanced Nonsquamous NSCLC
Bằng: Yuto Terashima, MD, et al.
Được phát hành: (2023-11-01)

Overview of Current Progress in Immune Checkpoint Inhibitor Therapy for Advanced Hepatocellular Carcinoma
Bằng: Xinlun Dai MD, et al.
Được phát hành: (2020-08-01)

Immune Checkpoint Inhibitor Plus Chemotherapy as First-Line Treatment for Advanced Gastric or Gastroesophageal Junction Cancer: A Systematic Review and Meta-Analysis
Bằng: Lianghui Zhang MS, et al.
Được phát hành: (2024-08-01)

A Comprehensive Study on the Prognostic Value and Clinicopathological Significance of Different Immune Checkpoints in Patients With Colorectal Cancer: A Systematic Review and Meta-Analysis
Bằng: Mahdieh Azizi, PhD, et al.
Được phát hành: (2024-01-01)

Identification of Novel Cuproptosis-Related Genes Mediating the Prognosis and Immune Microenvironment in Cholangiocarcinoma
Bằng: Qiang Liu PhD, et al.
Được phát hành: (2024-04-01)

Comprehensive Characterization of Cardiac, Skeletal and Diaphragmatic Myotoxicity Using CMR in Patients with Immune Checkpoint Inhibitor Therapy and Relation to Outcomes
Bằng: Etienne Charpentier, MD, et al.
Được phát hành: (2024-01-01)

Dosimetric Modeling of Lymphopenia in Patients With Metastatic Cancer Receiving Palliative Radiation and PD-1 Immune Checkpoint Inhibitors
Bằng: Jack M. Qian, MD, et al.
Được phát hành: (2022-03-01)

Impact of Immune Checkpoint Inhibitors and Local Radical Treatment on Survival Outcomes in Synchronous Oligometastatic NSCLC
Bằng: Mandy Jongbloed, MD, et al.
Được phát hành: (2025-03-01)

Cardiac Adverse Events Related to Immune Checkpoint Inhibitors∗
Bằng: Dorothy M. Gujral, PhD, et al.
Được phát hành: (2020-02-01)

A Retrospective Study on Therapeutic Efficacy of Transarterial Chemoembolization Combined With Immune Checkpoint Inhibitors Plus Lenvatinib in Patients With Unresectable Hepatocellular Carcinoma
Bằng: Ying Teng PhD, et al.
Được phát hành: (2022-03-01)

IgA pemphigus as an immune checkpoint inhibitor-associated skin manifestation
Bằng: Tristan V.M. Bruijn, MD, et al.
Được phát hành: (2024-05-01)

Synchronous Oligometastasis and Oligoprogression as a Prognostic Marker in Patients With Extensive-Stage SCLC Treated With a Combination of Immune-Checkpoint Inhibitor and Chemotherapy (HOT2301)
Bằng: Kana Hashimoto, MD, et al.
Được phát hành: (2024-11-01)

IL-23 inhibitor treatment of immune checkpoint inhibitor-associated psoriasis: Case series and review of literature
Bằng: Natalie Bourand, MS, et al.
Được phát hành: (2025-02-01)

Inhibits Murine Leukemia WEHI-3 Cells and Promotes Immune Response In Vivo
Bằng: Hsin-Ling Yang PhD, et al.
Được phát hành: (2017-09-01)

Immune Checkpoint Inhibitor Uptake in Real-World Patients With Malignant Pleural Mesothelioma
Bằng: Roger Y. Kim, MD, et al.
Được phát hành: (2021-06-01)

Kidney Disease Patient Representation in Trials of Combination Therapy With VEGF-Signaling Pathway Inhibitors and Immune Checkpoint Inhibitors: A Systematic Review
Bằng: Benjamin M.P. Elyan, MBChB, et al.
Được phát hành: (2023-07-01)

Immune Checkpoint Inhibitors in Patients With Cancer and Infection by Hepatitis B or C Virus: A Perspective Through the Results of a European Survey
Bằng: Marco Tagliamento, MD, et al.
Được phát hành: (2023-01-01)

Lessons From the Development of the Immune Checkpoint Inhibitors in Oncology
Bằng: Denis L. Jardim MD, PhD, et al.
Được phát hành: (2018-12-01)

Seeking “protective” and “harmful” immune genes during chronic HIV-1 infection by transcriptome analysis
Bằng: Lingyan Zhu, PhD, et al.
Được phát hành: (2018-09-01)

Immune Checkpoint Inhibitors for the Therapy of Thymoma
Bằng: Alicia Quilez, MD, et al.
Được phát hành: (2020-03-01)

Characteristics and immune checkpoint inhibitor effects on non-smoking non-small cell lung cancer with KRAS mutation
Bằng: Jia-Jun Wu, MD, et al.
Được phát hành: (2022-06-01)

The Value of Combined Detection of Megakaryocyte and Platelet Parameters for the Diagnosis of Primary Immune Thrombocytopenia
Bằng: Weiwei Wang MS, et al.
Được phát hành: (2022-08-01)

Severe recalcitrant cutaneous eruption with dual immune checkpoint blockade
Bằng: Sakeena Fatima, BA, et al.
Được phát hành: (2018-04-01)